US Halts AstraZeneca Vaccine Production at Baltimore Plant: Report

The US government detained on Saturday Baltimore manufacturing plant that ruined 15 million doses of Johnson & Johnson’s Covid-19 vaccine by manufacturing the vaccine developed by AstraZeneca Plc, the New York Times reported.
J&J said in a statement that it was “assuming full responsibility regarding the manufacturing of the drug substance for its Covid-19 vaccine at the Emergent BioSolutions Inc. Bayview facility.”
He did not specify whether he will take over the plant. The company did not respond to Reuters requests for comment for clarification.
The New York Times reported that AstraZeneca It said in a statement that it will work with President Joe Biden’s administration to find an alternative site. The drugmaker did not respond to a request for comment.
The move by the U.S. Department of Health and Human Services will make the Emergent BioSolutions facility dedicated exclusively to manufacturing Johnson & Johnson’s single-dose vaccine, and is intended to prevent future confusion, according to the newspaper report, that cites two senior federal health officials
The US government’s top infectious disease doctor told Reuters the country may not need the AstraZeneca vaccine, even if it gets approval.


Source link